Dow Jones 30 Stocks SEC Filings — March 23, 2026

23-03-2026

AbbVie Inc. released its 2026 Proxy Statement for the Annual Meeting on May 8, 2026, highlighting strong 2025 performance with total net revenues of $61.2B (up 8.5% operationally vs. 2024) driven by Growth Platform revenues of $56.6B (up 19.6% vs. 2024, comprising 93% of total), operating cash flow of $19.0B, and adjusted R&D investment of $13.8B. Key proposals include electing four directors (Jennifer L. Davis, Melody B. Meyer, Robert A. Michael, Frederick H. Waddell), ratifying Ernst & Young LLP as auditor, advisory vote on executive compensation, management proposal to eliminate supermajority voting (recommended FOR), and a stockholder proposal for an independent board chair (recommended AGAINST). Over the past decade, market capitalization increased by $309B, quarterly dividend rose to $1.73 per share, and total stockholder return reached +485%.

• ·Record date: March 9, 2026
• ·Meeting held virtually at www.virtualshareholdermeeting.com/ABBV2026
• ·Nine key assets achieved at least double-digit sales growth in 2025, including Skyrizi (+nearly 50%) and Rinvoq (+40%)
• ·Total stockholder return +485% over the last decade (2015-2025)

23-03-2026

Technology & Telecommunication Acquisition Corp (TETE) has filed a DEFM14A proxy statement dated March 23, 2026, for an extraordinary general meeting on or after the record date of February 25, 2026, to approve a Business Combination with Super Apps and Holdings, resulting in PubCo listing on Nasdaq as RADB, subject to approval. Post-merger ownership remains stable across minimum, mid-point, and maximum redemption scenarios, with Holdings shareholders at 85.3-85.4% (basic) or 58.4% (fully diluted), Sponsor at 10.7%/9.3%, and public shareholders at a low 1.6-1.7%/29.7%; a $5.0M PIPE is committed (with $16.0M interest), but the trust account holds only $142,275.91 as of February 23, 2026, signaling potentially high redemptions. The merger will make PubCo a controlled company with Bradbury Private Investment XVIII holding 34.5% voting power, and includes Sponsor forfeitures of 447,952 shares and contingent shares to MobilityOne.

• ·Non-Redemption Agreements dated January 19, 2025 (150,000 shares forfeited) and April 14, 2025 (297,952 shares forfeited), terminated but forfeiture obligation survives.
• ·TETE incorporated November 8, 2021; Class A shares, warrants, units listed on OTC Pink Current January 23, 2025 under TETEF, TETWF, TETUF.
• ·Nasdaq listing approval for RADB is a closing condition, waivable by Holdings and Super Apps.
• ·Shareholder meeting requests for additional documents by March 19, 2026.

23-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 23, 2026, announcing the issuance of a press release regarding the integration of RAD devices into the Immix platform by AITX's RAD and Immix entities. No financial metrics, performance comparisons, or quantitative impacts were disclosed in the filing.

23-03-2026

CECO Environmental Corp. presented at the 38th Annual Roth Conference on its proposed merger with Thermon Group Holdings, Inc., offering $10 cash per Thermon share plus 0.684 CECO shares, with expected cost synergies >$40M (75% by end-2027) and ~2.5x net leverage at close. CECO standalone delivered FY25 revenue of $774M (up ~39% YoY from $558M) and Adjusted EBITDA of $90M (up ~43% YoY from $63M), though gross profit margins remained flat at 35%; FY26 guidance raised to $925-975M revenue (+23% YoY midpoint) and $115-135M Adjusted EBITDA (+38% YoY midpoint) on a $6.5B+ pipeline. The deal requires shareholder and regulatory approvals amid risks including integration challenges and potential failure to achieve synergies.

• ·CECO cumulative stock return ~700% since March 2020 vs. S&P 500 ~73% and Russell 2000 ~24%.
• ·Pipeline growth ~430% since full year 2021; orders ~415% and revenue ~290%.
• ·End-market mix FY25E: 50% highly engineered, 25% standard/lightly engineered, 25% short cycle/parts/aftermarket.
• ·CECO stock price $55.28 as of March 20, 2026 close.

23-03-2026

PMGC Holdings Inc. (ELAB) entered into Amendment No. 5 on March 17, 2026, to its consulting agreement with GB Capital Ltd (wholly owned by CEO/CFO/Director Graydon Bensler), setting the annual consultant fee at $300,000 effective January 1, 2026. The company also entered into a similar Amendment No. 5 with Northstrive Companies Inc. (wholly owned by Chairman Braeden Lichti), setting the annual fee at $360,000 effective the same date. These amendments restate fee provisions of prior agreements originally dated October 25, 2024, with no other changes.

• ·Original consulting agreements dated October 25, 2024
• ·Prior amendments dated April 3, 2025; August 12, 2025; October 16, 2025
• ·Filing date: March 23, 2026

23-03-2026

Honeywell International Inc. announced the results as of March 19, 2026, and pricing for its tender offers to purchase certain existing debt securities, with settlement expected on March 24, 2026. Upon settlement, the special mandatory redemption obligation on $10B aggregate principal amount of Honeywell Aerospace senior notes (including $1.25B 3.900% due 2028, $1.25B 4.000% due 2029, and others up to 4.950% due 2036) will cease. This supports the planned Spin-Off of Honeywell Aerospace Inc.

• ·Tender offer results cutoff: 5:00 p.m. New York City time on March 19, 2026.
• ·Press releases on tender offer results (Exhibit 99.1) and pricing (Exhibit 99.2) dated March 20, 2026.
• ·Honeywell common stock and various senior notes traded on Nasdaq Stock Market LLC.

23-03-2026

On March 17, 2026, Volato Group, Inc. received a notice from NYSE American LLC indicating non-compliance with continued listing standards under Sections 1003(a)(i) and 1003(a)(ii) of the Company Guide due to stockholders’ equity below $2.0M (for losses in two of three recent fiscal years) and $4.0M (for losses in three of four recent fiscal years). The Company must submit a compliance plan by April 16, 2026, to regain standards by December 17, 2026, or face delisting proceedings, though there is no immediate impact on trading of its Class A Common Stock (SOAR) on NYSE American. Warrants (SOARW) trade on OTC Markets Group, Inc.

• ·Company address: 1954 Airport Road, Suite 124, Chamblee, GA 30341
• ·Telephone: 844-399-8998
• ·SEC Commission File Number: 001-41104
• ·IRS Employer Identification No.: 86-2707040
• ·Emerging growth company status: Yes

23-03-2026

AMERICAN REBEL HOLDINGS INC (formerly CUBESCAPE INC) filed an 8-K on March 23, 2026, covering Items 3.03 (material modifications to rights of security holders), 5.03 (charter or bylaws amendments), 7.01 (Regulation FD disclosure), and 9.01 (financial statements and exhibits). The filing is categorized under Charter/Bylaws Amendments as a material event, with no quantitative financial data, period-over-period comparisons, improvements, declines, or flat performance disclosed in the provided metadata. No additional positive or negative metrics are available.

• ·Company CIK: 0001648087
• ·SIC: 3490 - MISCELLANEOUS FABRICATED METAL PRODUCTS
• ·State of Incorporation: NV; Location: TN; Fiscal Year End: December 31
• ·Mailing/Business Address: 218 3RD AVENUE NORTH, #400, NASHVILLE TN 37201
• ·Phone: 833-267-3235

23-03-2026

Verde Clean Fuels, Inc. appointed George Burdette, its current CFO since October 2024, as new CEO, succeeding Ernie Miller who is stepping down to pursue other opportunities but will remain as a senior advisor. The company engaged Roth Capital Partners as a financial advisor to evaluate strategic alternatives, including potential merger, sale, or other transactions involving its STG+® technology, as part of ongoing restructuring and cost reduction initiatives. While positioned as a step to maximize shareholder value through capital-lite opportunities, the process has no set timetable and no assurance of any transaction.

• ·George Burdette previously served as CFO of Arbor Renewable Gas and Itafos, and head of project finance at First Solar.
• ·No binding agreements entered for strategic alternatives; company does not intend to disclose developments unless required.
• ·Announcement dated March 20, 2026; SEC filing March 23, 2026.

23-03-2026

Finwise Bancorp reported net income of $16.1M for the year ended December 31, 2025, up 26% from $12.7M in 2024, fueled by non-interest income surging 160% to $58.5M and net interest income growing 23% to $72.2M, alongside total assets expanding 31% to $977M and deposits rising 38.5% to $755M. However, provisions for credit losses ballooned to $38.6M from $11.6M, non-interest expenses increased 33% to $70.3M, net interest margin declined to 9.23% from 9.99%, and total equity to assets ratio fell to 19.8% from 23.3%. Segment-wise, BaaS contributed strongly with $10.5M net income, but Traditional Banking net income was $2.9M.

• ·BaaS segment net income $10.5M, Traditional Banking $2.9M, Treasury/Other $2.7M.
• ·Loans held-for-investment net grew 20.9% to $541.6M.
• ·Credit enhancement income $23.9M (up 21,453%), but related expenses surged (servicing +112,135%, guarantee +111,846%).
• ·Average yield on loans held-for-investment declined to 12.17% from 12.27%, net of credit enhancement to 10.35% from 12.27%.

23-03-2026

Faraday Future Intelligent Electric Inc. announced that the SEC has concluded its years-long investigation into 2021 PIPE and SPAC-related transactions with no enforcement action against the Company, founder and Co-CEO YT Jia, President Jerry Wang, or other team members, removing a major regulatory overhang. This provides clarity to pursue strategic financing, partnerships, Nasdaq compliance within 180 days without a reverse split, and focus on EAI vehicles and robotics. However, forward-looking statements highlight ongoing risks including liquidity shortages, potential delisting if share price falls below $0.10 for 10 days, substantial dilution needs, and execution challenges on vehicle deliveries and robotics.

• ·Nasdaq compliance notice received March 20, 2026, granting 180-day period to meet $1 minimum bid price without reverse stock split.
• ·SEC investigation originated from independent director probe in October 2021 related to SPAC merger.
• ·FF 91 deliveries began in 2023; Super One deliveries planned for 2026; Embodied AI Robotics sales beginning in 2026.

23-03-2026

ReserveOne Holdings, Inc. (Pubco) announced on March 20, 2026, the filing of a second amendment to its Form S-4 registration statement with the SEC for its proposed business combination with M3-Brigade Acquisition V Corp., following initial announcement on July 8, 2025, and prior filings on December 5, 2025, and February 17, 2026, indicating progress in the SEC review. Upon closing, subject to SEC effectiveness, shareholder approval, and other conditions, Pubco expects Nasdaq listing under 'RONE'. However, the filing highlights significant risks including potential delays or failure to close, high shareholder redemptions, cryptocurrency volatility, regulatory uncertainties, and operational challenges for the early-stage digital asset firm.

• ·SEC filing date: March 23, 2026 (Form 425)
• ·M3-Brigade tickers: NASDAQ: MBAVU, MBAV, MBAVW
• ·Expected Pubco ticker post-closing: RONE on Nasdaq
• ·ReserveOne website: www.reserveone.com
• ·M3-Brigade website: www.m3-brigade.com/m3-brigade-acquisition-iii-corp

23-03-2026

Avalo Therapeutics' 10-K shows a sharp decline in cash and equivalents to $15.9M as of Dec 31, 2025 from $134.5M in 2024, driven by a net cash decrease of $118.6M versus a $127.1M increase prior year, with operating cash use rising 5% to $51.5M and financing inflows dropping 92% to $14.6M. Total assets fell 23% to $116.5M while stockholders' equity decreased 38% to $83.0M amid a $78.3M worsening of accumulated deficit to $(448.5M). However, interest income grew 31% to $4.4M and common shares outstanding more than doubled to 18.5M.

• ·Executives adopted Rule 10b5-1 trading plans in November 2025 for future sales of up to 471,718 shares total, expiring mid-to-late 2026.
• ·Derivative liability increased to $18.0M non-current (from $8.1M) with $9.5M negative fair value change in 2025.
• ·Series C Preferred Stock outstanding decreased to 18,792 shares from 24,896.

23-03-2026

RenovoRx announced an oversubscribed $10M at-market private placement of ~10.6M common shares at $0.938/share (insiders at $1.029/share) plus milestone warrants for ~5.3M shares, anchored by life science institutional investors and participated in by senior management and board members. Proceeds will accelerate RenovoCath commercialization, which generated $900k in revenue over the first nine months of 2025 from initial purchase orders including repeat and new NCI-designated centers, and advance the Phase III TIGeR-PaC trial to full enrollment by mid-2026 with data in 2027. The financing supports goals of increasing revenue, reducing cash burn, and achieving cash-flow breakeven, with warrants tied to a $1.5M quarterly revenue milestone.

• ·Private placement priced at $0.938 per share for investors ($1.029 for executives/board); warrant exercise at $1.751 ($1.933 for executives/board), exercisable immediately, expire 30 days after $1.5M quarterly revenue announcement or March 30, 2029
• ·Expected closing March 20, 2026, subject to customary conditions
• ·First commercial RenovoCath purchase orders received December 2024
• ·RenovoCath has FDA clearance and Orphan Drug Designation (via IAG) for pancreatic and bile duct cancer

23-03-2026

AParadise Acquisition Corp., a SPAC listed on Nasdaq (APADU, APAD, APADR), released its PFIC Annual Information Statement for fiscal year 2025 (Jan 1 to Dec 31, 2025) on March 23, 2026, reporting per-share per-day ordinary earnings of $0.000605 and no net capital gains or distributions. The statement assists US shareholders with potential QEF elections under IRC Section 1295 and confirms the company may be treated as a PFIC. No other financial metrics or period comparisons were provided.

• ·Company incorporated November 9, 2022 in British Virgin Islands.
• ·Taxpayer Identification Number: N/A.
• ·Principal address: The Sun’s Group Center, 29th Floor, 200 Gloucester Road, Wan Chai, Hong Kong.
• ·Emerging growth company: Yes.

23-03-2026

Victory Capital Holdings, Inc. (VCTR) issued a press release on March 23, 2026, in connection with its previously announced proposal to acquire Janus Henderson Group plc. The filing contains standard forward-looking statements highlighting risks such as regulatory approvals, stockholder consents, potential litigation, business disruptions, and failure to realize expected synergies or benefits. No specific financial terms, deal progress, or quantitative updates on the proposed transaction are disclosed.

• ·Securities registered: Common Stock, Par Value $0.01, Trading Symbol VCTR on NASDAQ
• ·Reference to Company's 2025 annual meeting proxy statement filed with SEC on March 28, 2025

23-03-2026

Cabaletta Bio reported Q4 and FY 2025 financial results showing increased R&D expenses of $36.2M (up 42% YoY) and $142.7M (up 47% YoY), respectively, driving a FY net loss of $167.9M (worse than $115.9M in 2024), though G&A expenses declined 22% to $6.4M in Q4. Cash position stood at $133.6M as of Dec 31, 2025 (down 19% from $164.0M prior year), extended by $30M raised post-period to fund operations into Q4 2026. Clinical progress includes rese-cel myositis BLA on track for 2027, no-preconditioning data expected 1H26, and automated manufacturing underway, with complete Phase 1/2 data from multiple RESET trials in 1H26.

• ·Registrational DM/ASyS cohort in RESET-Myositis enrolling 17 patients with 16-week primary endpoint.
• ·First clinical experience with Cellares automated manufacturing expected 1H26; longer-term data 2H26.
• ·In first 40 rese-cel patients with preconditioning: 95% no/Grade 1 CRS, 95% no ICANS.
• ·Cash runway extended to Q4 2026 with post-period $30M raise.
• ·Oral presentation on RESET-MG data at AAN Annual Meeting, April 20, 2026.

23-03-2026

The Progressive Corporation filed a DEFA14A (Definitive Additional Proxy Materials) on March 23, 2026, as part of Schedule 14A under Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is marked as definitive additional materials, not preliminary or soliciting material.

23-03-2026

Two Harbors Investment Corp. announced via press release that its ad hoc committee determined CrossCountry Mortgage, LLC's unsolicited cash proposal to acquire all outstanding common shares for $10.70 per share constitutes a 'Company Superior Proposal' under the existing merger agreement with UWM Holdings Corporation dated December 17, 2025, with notice delivered to UWMC on March 21, 2026. The Company also received a higher unsolicited $10.75 per share cash proposal from an unnamed third party, deemed likely to lead to another superior proposal. This development creates uncertainty around the prior UWMC merger, potentially benefiting shareholders with higher bids but introducing deal risks and litigation possibilities.

• ·Merger agreement dated December 17, 2025, by and among the Company, UWM Acquisitions 1, LLC, and UWM Holdings Corporation.
• ·Press release attached as Exhibit 99.1.
• ·Filing includes forward-looking statements with risks related to transaction completion, stockholder approval, and market impacts.

23-03-2026

On March 19, 2026, Barnwell Industries, Inc. issued a press release highlighting its Canadian oil production assets in light of recent increases in global energy prices. The release also provides an update on the Company's ongoing evaluation of strategic alternatives for those assets. The 8-K was filed on March 23, 2026, with the press release attached as Exhibit 99.1.

23-03-2026

This DEF 14A proxy statement, filed March 23, 2026, seeks shareholder approval to elect four Class I directors (Jennifer L. DiMotta, Jeffrey G. Ludwig, Richard T. Ramos, Jeffrey C. Smith) for terms expiring in 2029, with detailed biographies for nominees and continuing directors. Nonemployee directors receive $40,000-$85,000 annual cash retainers, committee fees ($3,000-$18,000), and $45,000 in fully vested RSUs granted June 30, 2025 (FMV $17.32/share), with special cash arrangements for James F. Deutsch paid to Patriot Financial Partners. Corporate responsibility highlights include solar power at 22 locations, 60% paperless customers, $2.0M in foundation donations since 2011, and 500 volunteer hours in 2025, with no performance declines noted.

• ·Ms. Edwards resigned from the board effective May 12, 2025.
• ·James F. Deutsch appointed to the board on February 3, 2026; his compensation paid to Patriot Financial Partners in cash instead of equity.
• ·Board structure: Class I (expiring 2029), Class II (2027), Class III (2028); Chair and CEO roles separate since 1988; all non-CEO directors independent.
• ·Company history: Over 140 years; female board member since 1903; diverse representation since before 2016 IPO.

23-03-2026

ParkerVision reported a reduced net loss of $7.4 million ($0.06 per share) for the year ended December 31, 2025, compared to $14.5 million ($0.16 per share) in 2024, driven by a $0.6 million gain on contingent payment obligations versus a $9.6 million loss prior year, though offset by a $3.0 million increase in share-based compensation including a $2.5 million one-time charge. Cash and equivalents decreased slightly to $4.4 million from $4.9 million, with $2.3 million in working capital supported by $4.5 million from a November 2025 share offering. Litigation updates feature an expedited CAFC appeal against Qualcomm but a postponement of MediaTek trials scheduled for March 2026.

• ·Total assets $5.4M at Dec 31, 2025 vs $5.9M at Dec 31, 2024.
• ·Contingent payment obligations $46.1M at Dec 31, 2025 vs $46.7M at Dec 31, 2024.
• ·Current liabilities flat at $2.4M.
• ·Gross margin negative $(199)K in 2025 vs $(229)K in 2024.

23-03-2026

Fathom Holdings Inc. and its subsidiaries (E4:9 Holdings LLC, IntelliAgent LLC, Fathom Realty Holdings LLC, and Verus Holdings Inc.) entered into a Security Agreement dated March 18, 2026, with Bed Bath & Beyond, Inc., granting a continuing security interest in their collateral to secure a subordinated secured promissory note with an initial principal of $2M. The agreement includes covenants on collateral maintenance, no dispositions without consent, and remedies upon default. No financial performance metrics or period-over-period comparisons are disclosed.

• ·Agreement filed as EX-10.1 with SEC 8-K on March 23, 2026, covering Items 1.01, 2.03, 9.01.
• ·Debtors' chief executive office and collateral location: 2000 Regency Parkway Drive, Suite 300, Cary, NC 27518.
• ·Requires 10 days' prior written notice for changes in name, location, or mergers.

23-03-2026

rYojbaba Co., Ltd. (RYOJ) filed its annual 20-F report on March 23, 2026, providing the table of contents and cautionary notes on forward-looking statements, with extensive disclosures on company risks including capital needs, PFIC status, competition in labor consulting and osteopathic clinic/beauty salon businesses, client concentration, geographic focus on Kyushu/Fukuoka, regulatory changes, and operational vulnerabilities like natural disasters and cybersecurity. No financial performance metrics, period-over-period comparisons, or quantitative data are included in the provided content. The report highlights potential dilution from fundraising and challenges in expansion, talent retention, and compliance.

23-03-2026

Janus Living, Inc. entered into the Amended and Restated Operating Agreement for its operating partnership, Janus Living OP, LLC, effective March 17, 2026, governing membership interests, capital contributions, distributions, management, allocations, transfers, and LTIP units. The LLC was originally formed on December 22, 2025, by Healthpeak OP, LLC, with amendments on January 22, 2026, for a name change and on January 23, 2026, for transfer of ownership interest to Janus Living, Inc. No financial metrics, performance changes, or quantitative impacts are disclosed in the agreement.

• ·Original formation date: December 22, 2025
• ·Prior amendments: January 22, 2026 (name change); January 23, 2026 (ownership transfer)
• ·Agreement includes provisions for LTIP Units, equity incentive plans, and REIT compliance (e.g., Adjustment Factor tied to Class A-1 REIT Shares)

23-03-2026

CervoMed Inc. (CRVO) filed an 8-K on March 23, 2026, under Items 7.01 and 9.01, disclosing a presentation available on its website (www.cervomed.com under 'Investors – Events and Presentations') for use in investor conferences and meetings. The information is furnished, not filed, with no admission of materiality, and is intended to be viewed alongside SEC filings and public announcements. No specific financial, operational, or performance data is included in the filing.

23-03-2026

Yunhong Green CTI Ltd reported net sales growth of 10% YoY to $19.7M for the year ended December 31, 2025 from $18.0M in 2024, driven by foil balloons (+11% to $12.8M, 65% of sales) and film products (+33% to $1.1M), while other products grew modestly 4% to $5.8M. However, Customer B sales declined 8% to $7.9M (40% of revenues from 47%), the company recorded a $1.7M impairment on Hubei assets (vs $0 prior year), and depreciation doubled to $641k. Management remains focused on core foil balloon products and leveraging Yunhong Group advancements in compostable materials.

• ·Credit facility entered September 2021, extended in 2025, expires April 2028; in compliance since inception.
• ·55,600 shares under option outstanding and exercisable at Dec 31, 2025, weighted average exercise price $15.20 (unchanged from 2024).
• ·Two customers (A and B) represent 81% of 2025 revenues.

23-03-2026

Blackstone Private Real Estate Credit and Income Fund sold 3,441,683 unregistered common shares (par value $0.01 per share) as of March 1, 2026, with the final number determined on March 20, 2026, raising $90 million pursuant to subscription agreements. The offering was exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S. No period-over-period comparisons are provided in the filing.

• ·Registrant incorporated in Delaware with Commission File Number 814-01853 and IRS Employer ID 33-6657275.
• ·Principal executive offices at 345 Park Avenue, New York, NY 10154.
• ·Emerging growth company that has elected not to use extended transition period for new accounting standards.

23-03-2026

TGE Value Creative Solutions Corp, a SPAC formed on June 13, 2025, reported total assets of $150.8M as of December 31, 2025, primarily from $150.1M in trust account investments related to 15M Class A ordinary shares at $10.01 per share redemption value. The company recorded a net income of $146K for the period from inception through year-end, driven by $236K in other income including trust interest and fair value changes, despite a $90K operating loss. However, shareholders' deficit stood at $5.58M, largely due to $12M accretion of redeemable shares.

• ·Promissory note to related party: $150K
• ·Deferred underwriting commissions: $6M (non-current liability)
• ·Basic and diluted EPS for Class A and B shares: $0.03
• ·Class B shares initially issued to Sponsor: 5,750,000 for $25K, with 750,000 forfeited

23-03-2026

VRM MSP Recovery Partners, LLC, managed by Virage Capital Management LP, provided a one-time $75,000 advance to MSP Recovery, LLC to support its accounts payables, conditional on immediate reimbursement from future loan proceeds (excluding short-term financing from Hazel Partners Holdings, LLC) and agreement to appoint Nader Tavakoli as Chief Restructuring Officer. This follows multiple prior consents allowing MSP Recovery to use recovery proceeds otherwise distributable to the Company. The agreement highlights ongoing liquidity pressures at MSP Recovery, with references to potential debtor-in-possession financing under Chapter 11.

• ·Prior consents via email/letters dated September 5, 2025; October 16, 2025; November 14, 2025; November 26, 2025; December 19, 2025; February 19, 2026
• ·LLC Agreement amendments: August 1, 2020; December 1, 2020; March 9, 2022; July 28, 2023; November 13, 2023

23-03-2026

Catheter Precision, Inc. (VTAK) completed Initial and Subsequent Series C Private Placements raising aggregate gross proceeds of $3.47M through issuance of 392,608 common shares and 3,470 Series C-1 Preferred shares convertible into up to 2,426,573 common shares at $1.43 initial conversion price. The proxy seeks stockholder approval for conversion of these and potential additional Series C-2, C-3, and up to $77.8M in C-4 Preferred shares (total potential up to $88.2M), as required under NYSE American rules for issuances exceeding 19.99% of outstanding common stock or voting power. No stockholder approval has been obtained yet, delaying full conversion and additional closings.

• ·Stockholder meeting required within 60 days of February 9, 2026 Initial Closing Date; if not approved, reconvene every 90 days until obtained or preferred shares redeemed.
• ·Series C Preferred conversion prices adjustable to 80% of applicable price (5-day VWAP or closing price) post-Effective Date or Stockholder Approval Date, subject to $0.35 floor (waivable by Company).
• ·Placement agent Dawson James entitled to 7.7% cash fee only on proceeds above $3.85M.
• ·Preferred stockholders have protective veto rights on adverse changes to terms, charter amendments affecting rights, or increasing authorized preferred shares.

23-03-2026

Appendix B of the BANK5 2023-5YR2 10-K filing details compliance assertions by multiple servicers (CWCAM, PBLS1, Midland, CoreLogic) with Regulation AB servicing criteria for asset-backed securities, primarily mortgage loan pools. Most applicable criteria are marked as performed directly by the company or responsible vendors, with several investor reporting and pool administration items designated as not applicable or not performed due to transaction structure. No material deficiencies or exceptions are reported across general servicing, cash collection, and asset administration categories.

• ·Filing date: March 23, 2026
• ·Standard timeframes referenced include deposits/postings within 2 business days, reconciliations within 30 calendar days, and resolution of reconciling items within 90 calendar days
• ·Multiple criteria (e.g., 1122(d)(1)(iii), 1122(d)(3)(ii)-(iv), various 1122(d)(4) items) marked as Not Applicable or Inapplicable across servicers

23-03-2026

The Cato Corporation reported a narrowed Q4 FY2025 net loss of $10.7 million ($0.55 per diluted share) versus $14.1 million ($0.74 per diluted share) in Q4 FY2024, though sales declined 3.4% to $150.0 million with same-store sales flat. Full-year FY2025 net loss improved to $5.9 million ($0.31 per diluted share) from $18.1 million ($0.97 per diluted share), with sales up a modest 0.7% to $646.8 million and same-store sales increasing 4%, supported by gross margin expansion to 33.3% from 32.0% and SG&A reduction. However, the company closed 48 stores, reducing its footprint to 1,069 locations from 1,117, amid plans to open up to 10 and close up to 40 more in FY2026.

• ·Q4 gross margin: 29.2% vs 28.0% prior year.
• ·FY2025 SG&A expenses: 35.0% of sales vs 36.0% prior year.
• ·Cash and equivalents: $16.8M as of Jan 31, 2026 vs $20.3M prior year-end.
• ·Plans for FY2026: open up to 10 new stores, close up to 40 underperforming stores.

23-03-2026

Slide Insurance Holdings, Inc. announced on March 23, 2026, that its Board of Directors authorized a common stock repurchase program of up to $125 million. The program has no expiration date and permits repurchases via open market transactions, privately negotiated deals, Rule 10b5-1 plans, or other methods, subject to stock price, trading volume, legal requirements, and market conditions. The company is not obligated to repurchase any shares.

23-03-2026

Coca-Cola Consolidated, Inc. (COKE) filed Definitive Additional Proxy Materials (DEFA14A) on March 23, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is categorized as Definitive Additional Materials for proxy solicitation. No financial metrics, performance data, or specific proposals are detailed in the provided filing header.

• ·Filed by the Registrant.
• ·Not filed by a party other than the Registrant.

23-03-2026

BARK, Inc. filed an 8-K on March 23, 2026, disclosing a press release (Exhibit 99.1) updating on recent cost reduction initiatives and the status of potential refunds for tariffs previously paid under the International Emergency Economic Powers Act. No quantitative financial impacts, outcomes, or period-over-period comparisons were provided in the filing.

23-03-2026

Comtech Telecommunications Corp. filed a Form S-3 shelf registration statement with the SEC on March 23, 2026, enabling the potential offering of up to $125 million in common stock, preferred stock, debt securities, warrants, purchase contracts, or units from time to time based on market conditions. The company's common stock (CMTL) had a last reported sale price of $3.66 per share on March 17, 2026, and trades on the Nasdaq Global Select Market. As a smaller reporting company, Comtech qualifies due to non-affiliate market value under $250M or annual revenue under $100M, allowing reduced disclosure obligations.

• ·Principal executive offices: 305 N 54th Street, Chandler, Arizona 85226; Phone: (480) 333-2200
• ·Incorporated in Delaware; I.R.S. Employer Identification Number: 11-2139466; Founded: 1967
• ·Reportable segments: Allerium (formerly Terrestrial and Wireless Networks) and Satellite and Space Communications

23-03-2026

Everest Group, Ltd. (NYSE: EG) announced a definitive agreement to sell its Canadian Retail Insurance operations, Everest Insurance Company of Canada, to The Wawanesa Mutual Insurance Company, marking a key step in its strategic repositioning and exit from Commercial Retail Insurance operations following the 2025 sale of renewal rights to AIG. The transaction is expected to deliver compelling value to shareholders and transition employees to Wawanesa, with closure anticipated in the second half of 2026 subject to regulatory approvals. No financial terms of the deal were disclosed.

• ·Transaction advisors: Ardea Partners LP (exclusive financial advisor to Everest), Debevoise & Plimpton LLP and Stikeman Elliott LLP (legal advisors to Everest); TD Securities (exclusive financial advisor to Wawanesa), Torys LLP (legal advisor to Wawanesa)
• ·Everest common stock (NYSE: EG) is a component of the S&P 500 index

23-03-2026

M2i Global, Inc. settled a lawsuit filed on June 18, 2025, by James Bernet, Kelsey James, LLC, and BCA Cares, LLC alleging breach of contract and securities fraud from 2022-2023 agreements, following a default judgment entered on November 12, 2025, awarding plaintiffs $18M in damages or 100M shares. Under the March 19, 2026, Settlement Agreement, the company will issue 12.5M common shares to James Bernet (with leak-out provisions), enabling mutual releases, dismissal of the action, and setting aside of the judgment, avoiding cash payment but resulting in shareholder dilution. The company's February 12, 2026, motion to set aside the judgment remains pending until shares are transferred.

• ·Lawsuit filed in District Court of Washoe County, Nevada.
• ·Motion to set aside default judgment filed February 12, 2026, pending before Second Judicial District Court of the State of Nevada.
• ·Settlement shares transfer to initiate within 5 business days of March 19, 2026, agreement; stipulation to dismiss within 5 days of Bernet's receipt.
• ·No admission of wrongdoing in settlement.

23-03-2026

Richmond Mutual Bancorporation, Inc. (RMBI) and The Farmers Bancorp, Frankfort, Indiana entered into a merger agreement on November 11, 2025, pursuant to which Farmers Bancorp will merge into RMBI, creating a combined bank holding company with approximately $2.6B in total assets and 25 branches across Indiana and Ohio. Farmers Bancorp shareholders will receive 3.40 shares of RMBI common stock per share (exchange ratio), valued at approximately $44.71 per share or $82.4M aggregate based on RMBI's closing price on the announcement date, with former Farmers shareholders owning ~38% of the combined company post-merger. The transaction is subject to shareholder approval at meetings in 2026 and includes standard risks such as potential changes in RMBI stock value.

• ·Merger agreement dated November 11, 2025; S-4 filing date March 23, 2026.
• ·RMBI trades on NASDAQ under 'RMBI'; Farmers Bancorp on OTC Pink under 'FABP'.
• ·Merger expected to qualify as tax-free reorganization under IRC Section 368(a), except for cash in lieu of fractional shares.
• ·Shareholder meetings: RMBI annual meeting and Farmers Bancorp special meeting scheduled for [·], 2026.
• ·I.R.S. Employer Identification No. for RMBI: 36-4926041.